Folgen
Iria Carballo Carbajal
Iria Carballo Carbajal
Zugehörigkeit unbekannt
Keine bestätigte E-Mail-Adresse
Titel
Zitiert von
Zitiert von
Jahr
Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology
A Zimprich, S Biskup, P Leitner, P Lichtner, M Farrer, S Lincoln, ...
Neuron 44 (4), 601-607, 2004
35172004
Lewy body extracts from Parkinson disease brains trigger α‐synuclein pathology and neurodegeneration in mice and monkeys
A Recasens, B Dehay, J Bové, I Carballo‐Carbajal, S Dovero, ...
Annals of neurology 75 (3), 351-362, 2014
7192014
Disease‐specific phenotypes in dopamine neurons from human iPS‐based models of genetic and sporadic Parkinson's disease
A Sánchez‐Danés, Y Richaud‐Patin, I Carballo‐Carbajal, ...
EMBO molecular medicine 4 (5), 380-395, 2012
6422012
Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin
N Exner, B Treske, D Paquet, K Holmström, C Schiesling, S Gispert, ...
Journal of Neuroscience 27 (45), 12413-12418, 2007
6242007
Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson's disease pathogenesis
VM Carballo-Carbajal I, Laguna A, Romero-Giménez J, Cuadros T, Bové J ...
Nature Communications, 973, 2019
2882019
Advances in Parkinson’s disease: 200 years later
NLG Del Rey, A Quiroga-Varela, E Garbayo, I Carballo-Carbajal, ...
Frontiers in neuroanatomy 12, 113, 2018
1682018
Aberrant epigenome in iPSC‐derived dopaminergic neurons from Parkinson's disease patients
R Fernández‐Santiago, I Carballo‐Carbajal, G Castellano, R Torrent, ...
EMBO molecular medicine 7 (12), 1529-1546, 2015
1492015
Selective α-synuclein knockdown in monoamine neurons by intranasal oligonucleotide delivery: potential therapy for Parkinson’s disease
D Alarcón-Arís, A Recasens, M Galofré, I Carballo-Carbajal, N Zacchi, ...
Molecular Therapy 26 (2), 550-567, 2018
1332018
Leucine-rich repeat kinase 2 induces α-synuclein expression via the extracellular signal-regulated kinase pathway
I Carballo-Carbajal, S Weber-Endress, G Rovelli, D Chan, B Wolozin, ...
Cellular signalling 22 (5), 821-827, 2010
1092010
The E3 ubiquitin ligases TRIM17 and TRIM41 modulate α-synuclein expression by regulating ZSCAN21
I Lassot, S Mora, S Lesage, BA Zieba, E Coque, C Condroyer, ...
Cell reports 25 (9), 2484-2496. e9, 2018
462018
The small GTPase RAC1/CED-10 is essential in maintaining dopaminergic neuron function and survival against α-synuclein-induced toxicity
H Kim, C Calatayud, S Guha, I Fernández-Carasa, L Berkowitz, ...
Molecular neurobiology 55, 7533-7552, 2018
412018
Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients
A Recasens, I Carballo-Carbajal, A Parent, J Bové, E Gelpi, E Tolosa, ...
Acta neuropathologica communications 6, 1-9, 2018
312018
Chitinase 3-like 1 is neurotoxic in primary cultured neurons
C Matute-Blanch, L Calvo-Barreiro, I Carballo-Carbajal, R Gonzalo, ...
Scientific reports 10 (1), 7118, 2020
302020
Intracellular crowding by age-dependent neuromelanin accumulation disrupts neuronal proteostasis and triggers Parkinson disease pathology
M Vila, A Laguna, I Carballo-Carbajal
Autophagy 15 (11), 2028-2030, 2019
292019
Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson’s disease. EMBO Mol Med 4: 380–395
A Sánchez-Danés, Y Richaud-Patin, I Carballo-Carbajal, ...
202012
Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson’s disease. EMBO Mol Med. 2012; 4 (5): 380–95
A Sánchez-Danés, Y Richaud-Patin, I Carballo-Carbajal, ...
Epub 2012/03/13. https://doi. org/10. 1002/emmm. 201200215 PMID: 22407749, 2012
142012
Validation of a reversed phase UPLC-MS/MS method to determine dopamine metabolites and oxidation intermediates in neuronal differentiated SH-SY5Y cells and brain tissue
M Gonzalez-Sepulveda, A Laguna, I Carballo-Carbajal, ...
ACS Chemical Neuroscience 11 (17), 2679-2687, 2020
112020
Modelling human neuronal catecholaminergic pigmentation in rodents recapitulates age-related multisystem neurodegenerative deficits
A Laguna, N Peñuelas, M Gonzalez-Sepulveda, A Nicolau, S Arthaud, ...
bioRxiv, 2023.08. 08.552400, 2023
12023
Correction to: the small GTPase RAC1/CED-10 is essential in maintaining dopaminergic neuron function and survival against α-synuclein-induced toxicity
H Kim, C Calatayud, S Guha, I Fernández-Carasa, L Berkowitz, ...
Molecular neurobiology 55, 7553-7554, 2018
12018
Modelling human neuronal catecholaminergic pigmentation in rodents recapitulates age-related neurodegenerative deficits
A Laguna, N Peñuelas, M Gonzalez-Sepulveda, A Nicolau, S Arthaud, ...
Nature Communications 15 (1), 8819, 2024
2024
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20